MyAverix Finance
US · Healthcare
Evotec SE (EVOTF)
Drug Manufacturers - Specialty & Generic
Evotec SE (EVOTF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EVOTF
Evotec SE (EVOTF) — FAQ
What is EVOTF's P/E ratio?
The price-to-earnings (P/E) ratio for Evotec SE (EVOTF) is 18.00 (data as of 2026-03-24).
Does Evotec SE pay a dividend?
Dividend yield is not available in the current snapshot for Evotec SE (EVOTF). Check the MyAverix Finance app for the latest dividend data.
What sector is Evotec SE in?
Evotec SE (EVOTF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is EVOTF listed on?
EVOTF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.